ONLY AVAILABLE IN PAID PLANS
Stat+: on Day 3 of Jpm, Pharma Threads a Needle With the White House, and Novo Nordisk Has an Eye on M&a
In a significant development, some analysts believe both the white house and drugmakers won in the standoff over drug prices. This story has implications for readers interested in understanding the broader context of current events.